Treating iron overload: the state of the art.
Hershko
C
C
Shaare Zedek Medical Center, Department of Hematology, Jerusalem, Israel. hershko@szmc.org.il
D001565:Benzoates / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D000077588:Deferasirox; D000077543:Deferiprone; D003676:Deferoxamine / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007501:Iron / Q000737:chemistry / Q000378:metabolism; D007502:Iron Chelating Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D019190:Iron Overload / Q000188:drug therapy*; D008958:Models, Molecular; D011728:Pyridones / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D016019:Survival Analysis; D014230:Triazoles / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use
D001565:Benzoates; D007502:Iron Chelating Agents; D011728:Pyridones; D014230:Triazoles; D000077543:Deferiprone; D007501:Iron; D003676:Deferoxamine; D000077588:Deferasirox